Improving Preterm Kidney Outcomes With Caffeine
Recruiting
Phase 2
Interventional Study
Kidney Injury
Pre-Term
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 12 Hours – 96 Hours
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 114 (estimated)
- Sponsor
- University of Wisconsin, Madison · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study is being done to see if additional caffeine citrate (20 milligrams per kilogram IV bolus) helps babies with low kidney oxygenation already being treated with caffeine citrate (20 milligrams per kilogram IV bolus on day of life (DOL) 1 followed by 8 milligrams per kilogram daily maintenance). The investigators hypothesize that additional caffeine will improve kidney oxygen levels, while …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Gestational age at birth between 23 0/7 and 29 6/7 weeks.
* Able to have near-infrared spectroscopy (NIRS) monitoring of cerebral and kidney oxygenation.
* Able to receive IV medications.
* Indwelling umbilical arterial catheter (UAC), umbilical venous catheter (UVC), peripher…
Contacts